Now available from Aniara Diagnostica: LIAPHEN™ Protein C, Immuno-turbidimetric method for the in vitro quantitative determination of Protein C antigen
Aniara Diagnostica is pleased to announce the availability of Liaphen™ Protein C, an Immuno-turbidimetric method for the in vitro quantitative determination of Protein C antigen in human citrated plasma, using a manual and automated method.
WEST CHESTER, Ohio, July 24, 2022 /PRNewswire-PRWeb/ — Aniara Diagnostica, a multi-national distributor of diagnostic and research agents, as well as screening tools, has strengthened its commitment to meeting today’s highest standards for product quality and cost-efficient delivery.
For Research Use Only. Not for Use in Diagnostic Procedures.
LIAPHEN™ Protein C is an immune-turbidimetric method, based on antigen-antibody reaction: Protein C antigen (PC:Ag) of the sample reacts with latex particles sensitized with rabbit antibodies, leading to latex particles agglutination. This agglutination can be directly detected through the change of absorbance. The absorbance change is directly proportional to the amount of PC:Ag in the sample.
Liaphen™ Protein C A120003-RUO click here for more information
The entire Aniara product line is available for purchase at http://www.aniara.com. The Company distributes products in North America, Sweden, Norway, Denmark, Finland, Lithuania, Latvia, Estonia and Iceland.
Maria Waldron, Aniara Diagnostica, 5133423018, firstname.lastname@example.org
SOURCE Aniara Diagnostica
The content is by PR Newswire. Headlines of Today Media is not responsible for the content provided or any links related to this content. Headlines of Today Media is not responsible for the correctness, topicality or the quality of the content.